Hypoxia is one of the key factors in RCC, correlating with poor prognosis in RCC progression and affecting activities at the cellular level, resulting in resistance of the tumour cells to VEGF-TKIs and ICIs. This evidence concerns the gene VEGFA and neoplasm.